Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States

por Fan, Yanni, Bender, Shaun, Shi, Weizhi, Zoz, Donald
Publicado 2020

Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry

por Salisbury, Margaret L., Conoscenti, Craig S., Culver, Daniel A., Yow, Eric, Neely, Megan L., Bender, Shaun, Hartmann, Nadine, Palmer, Scott M.
Publicado 2020

Hospitalizations in patients with idiopathic pulmonary fibrosis

por Kim, Hyun J., Snyder, Laurie D., Adegunsoye, Ayodeji, Neely, Megan L., Bender, Shaun, White, Eric S., Conoscenti, Craig S., Strek, Mary E.
Publicado 2021

Disparities in Lung Transplant among Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the IPF-PRO Registry

por Swaminathan, Aparna C., Hellkamp, Anne S., Neely, Megan L., Bender, Shaun, Paoletti, Luca, White, Eric S., Palmer, Scott M., Whelan, Timothy P. M., Dilling, Daniel F.
Publicado 2022

Lung function trajectories in patients with idiopathic pulmonary fibrosis

por Neely, Megan L, Hellkamp, Anne S, Bender, Shaun, Todd, Jamie L, Liesching, Timothy, Luckhardt, Tracy R, Oldham, Justin M, Raj, Rishi, White, Eric S, Palmer, Scott M
Publicado 2023

In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study

por Durheim, Michael T., Judy, Jennifer, Bender, Shaun, Baumer, Dorothy, Lucas, Joseph, Robinson, Scott B., Mohamedaly, Omar, Shah, Bimal R., Leonard, Thomas, Conoscenti, Craig S., Palmer, Scott M.
Publicado 2019

A retrospective study of in-hospital mortality in patients with idiopathic pulmonary fibrosis between 2015 and 2018

por Durheim, Michael T., Judy, Jennifer, Bender, Shaun, Neely, Megan L., Baumer, Dorothy, Robinson, Scott B., Conoscenti, Craig S., Leonard, Thomas B., Lazarus, Howard M., Palmer, Scott M.
Publicado 2020

Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial

por Saran, Frank, Welsh, Liam, James, Allan, McBain, Catherine, Gattamaneni, Rao, Jefferies, Sarah, Harris, Fiona, Pemberton, Karine, Schaible, Jennifer, Bender, Shaun, Cseh, Agnieszka, Brada, Michael
Publicado 2021

Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry

por Kim, Hyun J., Snyder, Laurie D., Neely, Megan L., Hellkamp, Anne S., Hotchkin, David L., Morrison, Lake D., Bender, Shaun, Leonard, Thomas B., Culver, Daniel A.
Publicado 2022

Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

por de Andrade, Joao A., Kulkarni, Tejaswini, Neely, Megan L., Hellkamp, Anne S., Case, Amy Hajari, Culver, Daniel A., Guntupalli, Kalpalatha, Bender, Shaun, Conoscenti, Craig S., Snyder, Laurie D.
Publicado 2022

Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Regis...

por Case, Amy Hajari, Hellkamp, Anne S., Neely, Megan L., Bender, Shaun, Dilling, Daniel F., Gulati, Mridu, Hotchkin, David L., Huie, Tristan J., Lancaster, Lisa, Snyder, Laurie D., Conoscenti, Craig S.
Publicado 2020

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial

por Goss, Glenwood D, Cobo, Manuel, Lu, Shun, Syrigos, Konstantinos, Lee, Ki Hyeong, Göker, Erdem, Georgoulias, Vassilis, Isla, Dolores, Morabito, Alessandro, Min, Young J, Ardizzoni, Andrea, Bender, Shaun, Cseh, Agnieszka, Felip, Enriqueta
Publicado 2021

Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry

por Snyder, Laurie, Neely, Megan L., Hellkamp, Anne S., O’Brien, Emily, de Andrade, Joao, Conoscenti, Craig S., Leonard, Thomas, Bender, Shaun, Gulati, Mridu, Culver, Daniel A., Kaner, Robert J., Palmer, Scott, Kim, Hyun Joo
Publicado 2019

Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry

por Snyder, Laurie D, Mosher, Christopher, Holtze, Colin H, Lancaster, Lisa H, Flaherty, Kevin R, Noth, Imre, Neely, Megan L, Hellkamp, Anne S, Bender, Shaun, Conoscenti, Craig S, de Andrade, Joao A, Whelan, Timothy PM
Publicado 2020

Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis

por Astor, Todd L., Goldberg, Hilary J., Snyder, Laurie D., Courtwright, Andrew, Hachem, Ramsey, Pena, Tahuanty, Zaffiri, Lorenzo, Criner, Gerard J., Budev, Marie M., Thaniyavarn, Tany, Leonard, Thomas B., Bender, Shaun, Barakat, Aliaa, Breeze, Janis L., LaCamera, Peter
Publicado 2023